Monday, November 4, 2024
HomeTagsAlterity Therapeutics

Alterity Therapeutics

Alterity Therapeutics Launches ATH434 Phase 2 Clinical Trial in Australia

Alterity Therapeutics, a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, announced that it has received approval in Australia from the...

Alterity Therapeutics Announces Regulatory Authorization to Proceed with ATH434 Phase 2 Clinical Trial

Alterity Therapeutics, a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, announced that the Italian Medicines Agency, or Agenzia Italiana del...

Alterity Therapeutics Announces Publication Demonstrating that ATH434 is Neuroprotective in Animal Model

Alterity Therapeutics , a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, announced that data in an animal model of Multiple...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics